Selecciona Idioma

martes, 19 de marzo de 2013

"Novartis and LDK378"

 Novartis are working in LDK378, it's a good new to scientific advance for cancer. Read this interesting article on FierceBiotech:


Novartis compound LDK378 receives FDA Breakthrough Therapy designation for ALK+ non-small cell lung cancer



No hay comentarios:

Publicar un comentario